| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 12th March 2020 | Barbara A Wood | 35,000 | Grant/award etc. | $0.00 | |
| 12th March 2020 | Angelos M. Stergiou | 95,000 | Grant/award etc. | $0.00 | |
| 12th March 2020 | John Thomas Burns | 15,000 | Grant/award etc. | $0.00 | |
| 31st December 2018 | Angelos M. Stergiou | 23,277 | Open or private sale | $1.25 | $29,189.36 |
Galena Biopharma
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Ticker: GALE
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1390478
Employees:
Exchange: None
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Cash at Carrying Value: $3 M (1%)
Assets, Current: $5 M (-36%)
Assets: $15 M (-12%)
Accounts Payable, Current: $2 M (-37%)
Accrued Liabilities, Current: $2 M (0%)
Liabilities, Current: $4 M (-18%)
Liabilities: $11 M (2%)
Common Stock, Value, Issued: $7 Th (40%)
Common Stock, Shares, Issued: $7 M (32%)
Additional Paid in Capital, Common Stock: $113 M (5%)
Retained Earnings (Accumulated Deficit): $110 M (0%)
Stockholders' Equity (Parent): $4 M (-37%)
Liabilities and Equity: $15 M (-12%)
Research and Development: $2 M (-44%)
News
DXP Enterprises Reports Third Quarter 2020 Results
6th November 2020
17 Arrested For Running Fake Call Centre In Delhi: Police
6th November 2020
Ubiquiti Inc. Reports First Quarter Fiscal 2021 Financial Results
6th November 2020
